However, precaution must be taken that the tumor suppressor effects of METCAM/MUC18 may not be manifested in other human ovarian carcinoma cell lines when the non-orthotopic route of injection is used, as shown in the case of BG-1 cell line below. This evidence concerns the gene MCAM and ovarian carcinoma.